Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 138 entries
View as:

An Efficacy and Safety Study With Integrated Pharmacokinetics (PK) and Pharmacodynamic (PD) Assessment to Compare the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis (RMS)

Phase: N/A Priority: Normal
NCT ID: NCT06847724 Org: User:
Start: 06/15/25 End: 10/14/29 Due: 10/14/30

To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00913718 Org: User:
Start: 06/30/96 End: 07/31/96 Due: 07/31/97

Relative Bioavailability of a Fentanyl Patch

Phase: N/A Priority: Normal
NCT ID: NCT00857753 Org: User:
Start: 09/30/06 End: 10/31/06 Due: 10/31/07

To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00913822 Org: User:
Start: 12/31/87 End: 12/31/87 Due: 12/31/88

A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00865033 Org: User:
Start: 11/30/05 End: 11/30/05 Due: 11/30/06

GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)

Phase: N/A Priority: Normal
NCT ID: NCT01419665 Org: User:
Start: 12/01/11 End: 01/22/18 Due: 01/22/19

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00913224 Org: User:
Start: 04/30/93 End: 04/30/93 Due: 04/30/94

To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00913809 Org: User:
Start: 12/31/87 End: 12/31/87 Due: 12/31/88

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00959933 Org: User:
Start: 04/30/01 End: 05/31/01 Due: 05/31/02

MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5

Phase: N/A Priority: Normal
NCT ID: NCT01121237 Org: User:
Start: 02/28/10 End: 11/30/14 Due: 11/30/15

A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and ANTI-ANGIN® FORMULA, Lozenges, in Treatment of Patients With a Sore Throat

Phase: N/A Priority: Normal
NCT ID: NCT03095521 Org: User:
Start: 02/22/17 End: 05/07/17 Due: 05/07/18

To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00881179 Org: User:
Start: 05/31/02 End: 06/30/02 Due: 06/30/03

A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia

Phase: N/A Priority: Normal
NCT ID: NCT00002258 Org: User:
Start: - End: - Due: -

To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00865670 Org: User:
Start: 08/31/03 End: 09/30/03 Due: 09/30/04

An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

Phase: N/A Priority: Normal
NCT ID: NCT00002008 Org: User:
Start: - End: - Due: -

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00881855 Org: User:
Start: 03/31/04 End: 04/30/04 Due: 04/30/05

To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00913783 Org: User:
Start: 11/30/92 End: 12/31/92 Due: 12/31/93

Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT03974100 Org: User:
Start: 07/02/19 End: 04/22/22 Due: 04/22/23

To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and Fed

Phase: N/A Priority: Normal
NCT ID: NCT00883506 Org: User:
Start: 05/31/00 End: 06/30/00 Due: 06/30/01

Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)

Phase: N/A Priority: Normal
NCT ID: NCT00537914 Org: User:
Start: 02/06/08 End: 03/25/22 Due: 03/25/23

To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00913419 Org: User:
Start: 11/30/88 End: 12/31/88 Due: 12/31/89

Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.

Phase: N/A Priority: Normal
NCT ID: NCT05590598 Org: User:
Start: 02/13/23 End: 06/14/23 Due: 06/14/24

A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

Phase: N/A Priority: Normal
NCT ID: NCT00002009 Org: User:
Start: - End: - Due: -

To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00883155 Org: User:
Start: 10/31/98 End: 10/31/98 Due: 10/31/99

To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00947128 Org: User:
Start: 09/30/04 End: 10/31/04 Due: 10/31/05